ABT
NYSE · Health Care
Abbott Laboratories
$91.05
-1.66 (-1.79%)
Analyst Consensus
Buy
34
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+35.6% upside
Low Target
$104.85
Average Target
$123.47
High Target
$190.33
Current Price
$91.05
Current
$91.05
$91.05
Target
$123.47
$123.47
$104.85
$123.47 avg
$190.33
Scenario Analysis
Bear Case
$104.85
15.2%
Low target
Base Case
$123.47
+35.6%
Avg target
Bull Case
$190.33
+109.0%
High target
Risk/Reward
7.2x
Highly favorable
Price in Context
52-Week High
$138.84
-34.4% from high
52-Week Low
$81.97
+11.1% from low
50-Day SMA
$118.82
-23.4% vs SMA
200-Day SMA
$127.91
-28.8% vs SMA
RSI (14)
69.3
Neutral
Target vs 52W High
$123.47
-11.1% vs high
Next Earnings Report
Jul 15, 2026 · Before Market Open
14d
until earnings
EPS Est: $1.29
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| UNH | Strong Buy | 34 | 76% | $293.85 | -29.4% |
| ABT | Buy | 34 | 71% | $123.47 | +35.6% |
| ISRG | Buy | 40 | 70% | $219.77 | -45.1% |
| CVS | Strong Buy | 33 | 82% | $162.09 | +55.9% |
| SYK | Strong Buy | 35 | 77% | $338.36 | +8.4% |
| MDT | Buy | 37 | 57% | $192.46 | +144.2% |
| MCK | Strong Buy | 23 | 87% | $307.39 | -59.2% |
| HCA | Buy | 30 | 63% | $118.82 | -69.4% |